相关实验视频

Updated: Sep 11, 2025

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

炎症性肠道疾病中的移动健康技术:叙述性审查

Adam M Burton^1,2, Bryce K Perler³

¹Department of Medicine, Brown University, Providence, RI, USA. aburton@brownhealth.org.

BMC gastroenterology

|August 18, 2025

概括

移动健康应用程序通过启用症状跟踪和提供者通信来增强炎症性肠病 (IBD) 管理. 这些技术赋予患者权力,并为临床医生提供个人化治疗计划的数据.

科学领域:

胃肠病学胃肠病学
数字健康数字健康
医疗信息学医疗信息学

背景情况:

传统的炎症性肠病 (IBD) 管理依赖于面对面的访问.
技术进步,特别是移动健康 (mHealth) 应用程序,正在改变IBD护理的提供.
智能手机和数字健康工具越来越多地融入患者护理.

研究的目的:

对IBD护理的流行的和经过充分研究的移动健康应用程序进行审查和比较.
为临床医生提供有关IBD当前mHealth技术的信息.
探索将mHealth应用程序集成到传统IBD护理模式中的潜力.

主要方法:

对IBD选择的mHealth应用程序进行审查和比较.
应用程序功能分析,包括症状跟踪,提供者沟通,营养支持,心理健康资源和患者教育.
探索当前的可穿戴技术和IBD护理的未来技术进步.

主要成果:

多种mHealth应用程序为IBD患者提供了多样化的功能.
应用程序促进症状和食物摄入量跟踪,与医疗保健提供者沟通,并获得教育和心理健康资源.
可穿戴技术为增强IBD患者护理提供了进一步的机会.

结论:

移动健康应用程序为IBD综合管理策略提供了巨大的潜力.
这些应用程序使患者能够在他们的护理中发挥更积极的作用.
来自mHealth应用程序的实时数据可以使临床医生能够为IBD患者制定更个性化的治疗计划.

关键词:

应用程序应用程序移动健康服务提供者技术技术技术技术技术可穿戴设备可以穿戴.

更多相关视频

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation

Published on: December 15, 2017

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation

Published on: September 11, 2012

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...